Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Mitterhauser

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 27, 2014
Imaging biomarkers or biomarker imaging?Markus Mitterhauser, Wolfgang Wadsak
Nuclear Medicine and Biology|July 2, 2011
Radiopharmaceutical considerations on bone seeker uptake: should we learn from therapeutical targets of bisphosphonates?Markus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|June 27, 2007
Evaluation of novel tropane analoguesMarkus Mitterhauser, Wolfgang Wadsak
Nuclear Medicine and Biology|November 5, 2017
Reconsider logP!Chrysoula Vraka, Markus Mitterhauser
ALTEX|March 25, 2008
An in vitro model for the comparative evaluation of bone seeking pharmaceuticalsMarkus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|November 26, 2008
What to consider in the development of new bone seekers: mechanistic and tracer-related aspectsMarkus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|September 16, 2024
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cellsJulia Raitanen, Lena Palm, Marcus Hacker, et al.
International Journal of Molecular Sciences|February 1, 2019
Binding Affinity of Some Endogenous and Synthetic TSPO Ligands Regarding the rs6971 PolymorphismNeydher Berroterán-Infante, Monika Tadić, Marcus Hacker, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Experimental Nuclear Medicine Meets Tumor BiologyTheresa Balber, Loan Tran, Katarína Benčurová, et al.
Dalton Transactions (Cambridge, England : 2003)|April 18, 2018
Microfluidic <sup>68</sup>Ga-labeling: a proof of principle studySarah Pfaff, Cecile Philippe, Verena Pichler, et al.
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Pharmaceuticals (Basel, Switzerland)|June 27, 2014
Imaging biomarkers or biomarker imaging?Markus Mitterhauser, Wolfgang Wadsak
Nuclear Medicine and Biology|July 2, 2011
Radiopharmaceutical considerations on bone seeker uptake: should we learn from therapeutical targets of bisphosphonates?Markus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|June 27, 2007
Evaluation of novel tropane analoguesMarkus Mitterhauser, Wolfgang Wadsak
Nuclear Medicine and Biology|November 5, 2017
Reconsider logP!Chrysoula Vraka, Markus Mitterhauser
ALTEX|March 25, 2008
An in vitro model for the comparative evaluation of bone seeking pharmaceuticalsMarkus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|November 26, 2008
What to consider in the development of new bone seekers: mechanistic and tracer-related aspectsMarkus Mitterhauser, Stefan Toegel
Nuclear Medicine and Biology|September 16, 2024
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cellsJulia Raitanen, Lena Palm, Marcus Hacker, et al.
International Journal of Molecular Sciences|February 1, 2019
Binding Affinity of Some Endogenous and Synthetic TSPO Ligands Regarding the rs6971 PolymorphismNeydher Berroterán-Infante, Monika Tadić, Marcus Hacker, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Experimental Nuclear Medicine Meets Tumor BiologyTheresa Balber, Loan Tran, Katarína Benčurová, et al.
Dalton Transactions (Cambridge, England : 2003)|April 18, 2018
Microfluidic <sup>68</sup>Ga-labeling: a proof of principle studySarah Pfaff, Cecile Philippe, Verena Pichler, et al.
Pageof 22